Physician

Robert Steven Siegel, M.D.

According to 2025 Medicare claims, Robert Siegel, M.D. (NPI: 1003985367) practices hematology/oncology in the Washington, DC-MD market, with the plurality of this provider's patient population coming from The District, DC. This provider's primary affiliated billing organization is MEDICAL FACULTY ASSOCIATES, INC (NPI: 1417990581; TIN: 522220700) and primary practice location at 20037-3201. Siegel is affiliated with the PBACO Holding, LLC (ACO ID: A1001), participating under the MSSP model.

Siegel's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 294 traditional Medicare patients, billed 66,427 HCPCS/CPT codes, and received $1,312,539 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 584 prescription claims across 92 beneficiaries totaling $3,111,087 in drug costs, led by Xtandi (Enzalutamide). 2018 DME data shows 46 claims. Open Payments data shows 50 records totaling $1,123. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved from a lower plateau to a higher plateau, from $1,274,175 to $1,312,539. Similarly, Part D prescription costs have moved from a lower plateau to a higher plateau, from $818,567 to $3,111,087. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.